Skip to content
PICO Portalanswers from OpenAlex

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?

PaperCitations, authors & open-access status

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? is a paper indexed in PICO Portal from OpenAlex.

How many citations does Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? have?

PICO Portalcitation count

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? has 89 citations in the OpenAlex counts PICO Portal stores.

When was Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? published?

PICO Portalyear

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? has 2016 year in the PICO Portal index.

What is the open-access status of Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor??

PICO Portaloa status

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? has gold oa status in the PICO Portal index.

What is the DOI of Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor??

PICO Portaldoi

The DOI for Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? is on the source record.

What is the PMID of Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor??

PICO Portalpmid

The PMID for Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? is on the source record.

What is the OpenAlex record for Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor??

PICO Portalopenalex

The OpenAlex for Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial